Teva Pharmaceutical Industries Ltd 2024 SR
The report details Teva's 2024 sustainability performance, highlighting the completion of its first Double Materiality Assessment in accordance with ESRS. Key achievements include a 29% reduction in Scope 1 and 2 emissions compared to a 2019 baseline and reaching 47% renewable electricity. The company committed to a net-zero target by 2045. Social highlights include providing 3.6 million tablets/doses through access programs in LMICs and maintaining a 49% representation of women in management positions.
Company: Teva Pharmaceutical Industries Ltd
Sector: Manufacturing
Country: Israel
Year: 2024
Type: SR
Pages: 92
Back to company
Teva Pharmaceutical Industries Ltd
Healthy Future Report Disclosures
The report details Teva's 2024 sustainability performance, highlighting the completion of its first Double Materiality Assessment in accordance with ESRS. Key achievements include a 29% reduction in Scope 1 and 2 emissions compared to a 2019 baseline and reaching 47% renewable electricity. The company committed to a net-zero target by 2045. Social highlights include providing 3.6 million tablets/doses through access programs in LMICs and maintaining a 49% representation of women in management positions.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women in Management
Workplace Fatalities
Net Zero Target
Employees